Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE43.5400
- TODAY'S CHANGE (%)-0.2100 (-0.4800%)
- Bid / Lots43.5000/ 2
- Ask / Lots43.5700/ 2
- Open / Previous Close43.8700 / 43.7500
- Day Range
- 52 Week Range
- Volume109,217
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 2485 | 44 |
| 09:34 ET | 116 | 43.815 |
| 09:36 ET | 351 | 44.2 |
| 09:38 ET | 700 | 44.12 |
| 09:41 ET | 1814 | 44.3672 |
| 09:43 ET | 1332 | 44.35 |
| 09:45 ET | 1000 | 44.35 |
| 09:48 ET | 1836 | 44.16 |
| 09:50 ET | 100 | 43.98 |
| 09:52 ET | 164 | 43.925 |
| 09:54 ET | 14721 | 43.78 |
| 09:56 ET | 510 | 43.58 |
| 09:57 ET | 800 | 43.75 |
| 09:59 ET | 800 | 43.75 |
| 10:03 ET | 1100 | 43.81 |
| 10:06 ET | 8272 | 43.995 |
| 10:08 ET | 200 | 43.96 |
| 10:10 ET | 100 | 44 |
| 10:12 ET | 11314 | 43.86 |
| 10:14 ET | 630 | 43.92 |
| 10:17 ET | 2806 | 43.81 |
| 10:19 ET | 2600 | 43.83 |
| 10:21 ET | 433 | 43.97 |
| 10:24 ET | 100 | 43.93 |
| 10:26 ET | 200 | 43.875 |
| 10:28 ET | 300 | 43.91 |
| 10:32 ET | 316 | 43.793 |
| 10:33 ET | 100 | 43.755 |
| 10:35 ET | 300 | 43.71 |
| 10:39 ET | 100 | 43.665 |
| 10:42 ET | 600 | 43.72 |
| 10:44 ET | 400 | 43.645 |
| 10:46 ET | 700 | 43.59 |
| 10:48 ET | 100 | 43.59 |
| 10:50 ET | 628 | 43.66 |
| 10:53 ET | 736 | 43.785 |
| 10:55 ET | 500 | 43.805 |
| 11:00 ET | 500 | 43.8 |
| 11:02 ET | 600 | 43.945 |
| 11:09 ET | 100 | 43.83 |
| 11:13 ET | 839 | 43.69 |
| 11:15 ET | 100 | 43.62 |
| 11:20 ET | 300 | 43.5475 |
| 11:22 ET | 777 | 43.65 |
| 11:24 ET | 106 | 43.65 |
| 11:27 ET | 1008 | 43.81 |
| 11:29 ET | 230 | 43.795 |
| 11:31 ET | 200 | 43.855 |
| 11:33 ET | 604 | 43.93 |
| 11:36 ET | 400 | 43.965 |
| 11:38 ET | 208 | 43.93 |
| 11:40 ET | 112 | 43.925 |
| 11:42 ET | 760 | 43.95 |
| 11:44 ET | 100 | 43.98 |
| 11:45 ET | 100 | 43.995 |
| 11:51 ET | 100 | 43.99 |
| 11:54 ET | 2965 | 43.965 |
| 11:56 ET | 1850 | 44.01 |
| 11:58 ET | 1600 | 43.89 |
| 12:02 ET | 1600 | 43.75 |
| 12:05 ET | 300 | 43.64 |
| 12:07 ET | 275 | 43.67 |
| 12:09 ET | 100 | 43.6225 |
| 12:14 ET | 1708 | 43.645 |
| 12:18 ET | 956 | 43.69 |
| 12:20 ET | 100 | 43.74 |
| 12:21 ET | 1400 | 43.655 |
| 12:23 ET | 100 | 43.65 |
| 12:27 ET | 100 | 43.655 |
| 12:32 ET | 1343 | 43.69 |
| 12:36 ET | 300 | 43.675 |
| 12:38 ET | 1100 | 43.655 |
| 12:41 ET | 100 | 43.61 |
| 12:43 ET | 300 | 43.54 |
| 12:45 ET | 200 | 43.54 |
| 12:48 ET | 100 | 43.54 |
| 12:50 ET | 328 | 43.51 |
| 12:52 ET | 232 | 43.45 |
| 12:54 ET | 100 | 43.415 |
| 12:56 ET | 100 | 43.39 |
| 12:57 ET | 100 | 43.405 |
| 12:59 ET | 200 | 43.37 |
| 01:01 ET | 271 | 43.41 |
| 01:06 ET | 1180 | 43.47 |
| 01:08 ET | 434 | 43.51 |
| 01:10 ET | 100 | 43.515 |
| 01:17 ET | 400 | 43.54 |
May 2, 2024
Apr 16, 2024
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting, from 8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 12, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham, from 7:13AM ET on Friday Apr 12, 2024 by Dow Jones
7:13AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:57AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:57AM ET on Wednesday Apr 10, 2024 by Dow JonesXenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, from 8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.3B | -16.0x | --- |
SpringWorks Therapeutics Inc | 3.3B | -8.9x | --- |
Janux Therapeutics Inc | 3.3B | -46.3x | --- |
Summit Therapeutics Inc | 3.1B | -2.9x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.1B | -31.2x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -16.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
